MedTrace Logo

Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions

NCT01947192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-02-24

No results posted yet for this study

Summary

This study aims to evaluate the effect of chlorhexidine digluconate (CRX) application in etched dentin on the retention of noncarious cervical lesions restorations.

A randomized controlled split-mouth and blind trial will be carried out. Patients with at least two non-carious cervical lesions (NCL) will be selected. NCL will be randomly assigned according the type of teeth (incisors, canine or pre-molars) into two groups: control or experimental group (application of 2% CRX for 60 seconds after the acid etching procedure). Class V restorations will be performed out with an etch-and-rinse adhesive system (Adper Single Bond 2-3M ESPE) and a composite resin (Filtek Z350-3M ESPE) according the manufacture instructions, by previously trained operators. The restorations will be evaluated by a calibrate examiner at 1 week (baseline), and 6-month, 12-month and 24-month, using the World Dental Federation (FDI) criteria. The outcome is retention of the restoration.

Conditions

  • Non-carious Cervical Lesions

Interventions

PROCEDURE

Treatment with chlorhexidine

Application of 2% chlorhexidine digluconate (60 seconds) after the etching procedure and before the adhesive system.

PROCEDURE

Water pre-treatment

Treatment of acid etched dentin with sterilized water for 60 s before adhesive system application

Sponsors & Collaborators

  • Federal University of Pelotas

    lead OTHER

Principal Investigators

  • Maximiliano Cenci, PhD · School of Dentistry-UFPel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947192 on ClinicalTrials.gov